MedTrace Logo

Reduction of Pulmonary Artery Pressure in Patients Subjected to Cardiac Surgery

NCT01597427 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2012-05-14

No results posted yet for this study

Summary

The aim of this study is to assess the ability of clonidine to reduce the mean pulmonary artery pressure in patients with pulmonary hypertension subjected to cardiac surgery.

Conditions

  • Anesthesia

Interventions

DRUG

Clonidine

Administration of 2 μg/kg of intravenous clonidine

DRUG

Placebo

Injection of placebo solution.

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Luiz Fernando R Falcao, Ph.D. · Federal University of São Paulo

  • Benedito B Joao, MD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-04-30
Completion
2012-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01597427 on ClinicalTrials.gov